🚀 Exciting News! The AI in Pharmaceutical Marketing & Regulatory Working Group is Officially underway! 🤖
We are thrilled to announce the successful completion of our inaugural sessions, where industry experts, marketers, and regulatory professionals came together to explore the transformative potential of AI in pharmaceutical marketing and regulatory. See a list of some of the members below.
Throughout the first session, we discussed early experiences with AI-driven strategies, compliance issues, internal change challenges, ethical considerations and the way we see these things shaping the future of our industry. The insights and experiences shared created a solid foundation for future discussions on integrating AI in a way that enhances efficiency, maintains regulatory integrity, and, most importantly, prioritizes patient safety.
Looking ahead, we are optimistic about continuing this journey and building a future where AI is a trusted and transparent tool that drives innovation in pharma marketing and regulatory. Stay tuned for updates as we work to bring these ideas to life!
Members:
Name | Title | Company |
Barb Marinac | Strategy Lead - Regulatory Affairs | Bayer Inc. |
Betty Davis | Market Specialist | Klick Health |
Bryan Roman | EVP, Experience Design & Technology | GSW NA |
Camille Kiffer | Digital Transformation and Operations | Lilly |
Jennifer Liang | Medical Information | Bayer Inc. |
Jonathan Chiriboga | Director, Marketing Innovation & Digital Excellence | Aastrazeneca Canada |
Mario Dilorio | Head of Customer Engagement, Partner | RXCHAINGE, bMod |
Mario Farina | Marketing Partner | Roche |
Moomal Effendi | Copy and Content Strategist | GSK |
Natalie Bourré | Healthcare Communications Consultant | Marketing 4 Health Inc. |
Paul Costea | Systems and Process Analyst @RocheCanada | Hoffmann - La Roche Ltd. Canada |
Samra Rehman | Marketing Manager | Astrazeneca Canada |
Simon Smith | EVP Generative AI | Klick Health |
Yasmine Kollar | Oncology Marketing Intern | Astrazeneca Canada |
Never miss an update. Get the latest PAAB info delivered right to your email address.
In an effort to constantly serve our clients better, PAAB has unveiled a new electronic submission process(eFiles). Effective January 2, 2008 all submissions will have to be submitted via the eFiles system. Please have a Senior Official (Director level) send an email to the administration team at review@paab.ca with the contact information of the person(s) who will be designated as administrator(s) for your company. Click on eFiles, on the menu, then eFiles Tutorial for a tutorial on how eFiles works.
Please contact the admin team at PAAB if you need assistance with eFiles
The Accelerated Preclearance Pathway
Learn more and share your feedback by April 14
Click here to provide feedback